CIS - To Treat or Not To Treat: Aye, there's the rub!

CIS conflict:

In thinking about Miller's Lancet's editorial on PreCISe (Treatment of clinically isolated syndrome: to be PreCISe) - online Oct 7, 2009, it is important to reference Pittock's August 4, 2007 Lancet editorial( Interferon beta in multiple sclerosis: how much BENEFIT?) and Pittock's Lancet Neurology's online September 11, 2009 2009 Reflection and Reaction on BENEFIT's disappointing 5-year disability data (Uncertain BENEFIT of early interferon beta-1b treatment).

So, is there consensus?

Apparently not.

Also, did anybody notice the upside down brain MRI in Miller's Lancet editorial?

- Dr. Daniel Kantor, MD BSE
Medical Director
Neurologique

info@neurologique.org
www.neurologique.org